Skip to content

13F-HR filed by BAILARD, INC.

BAILARD, INC. filed this 13F-HR for the quarter ended 2018-06-30, filed 2018-08-08, with 510 holding rows worth $1,678,590,000.

Accession
0001085146-18-001894
Filed
2018-08-08
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2018

A holdings report, 510 entries on the cover page, a total value of $1,678,590,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,678,590,000 with VALUE read as thousands by filing date, 13F file number 028-01707. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
TRANSCAT INC893529107COM10,356$196,000thousands by filing date
SPEEDWAY MOTORSPORTS INC847788106COM11,300$196,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW41,000$176,000thousands by filing dateput
EPIZYME INC29428V104COM12,000$163,000thousands by filing date
MITSUBISHI UFJ FINANCIAL GROUP SPONSORED ADS606822104ADR25,971$147,000thousands by filing date
IMMUNOMEDICS INC452907108COM53,500$134,000thousands by filing dateput
SPARK THERAPEUTICS INC84652J103COM33,000$123,000thousands by filing dateput
GLOBAL BLOOD THERAPEUTICS USD37890U108COM34,000$78,000thousands by filing dateput
DERMIRA INC24983L104COM108,000$22,000thousands by filing dateput
NAVIDEA BIOPHARMACEUTICALS I63937X103COM10,000$2,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001085146-18-001894this filing2018-08-08acceptance time not in the bulk data set